Clinical trial
Finerenone and Cardiac Remodeling: A Randomized, Double- Blind, Placebo-Controlled Study to Evaluate The Effects of Finerenone on Ventricular Remodeling
NCT07270367 is registered in ClinicalTrials.gov with Subodh Verma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Finerenone and Cardiac Remodeling: A Randomized, Double- Blind, Placebo-Controlled Study to Evaluate The Effects of Finerenone on Ventricular Remodeling
- Lead sponsor
- Subodh Verma
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- December 31, 2030
- Enrollment
- 156 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.